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Dementia after stroke increases the risk 
of long-term stroke recurrence 
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D.W. Desmond, PhD 
Article abs t rac tBackground:  Although risk factors for first stroke have been identified, the predictors of long-term 
stroke recurrence are less well understood. We performed the present study to determine whether dementia diagnosed 
three months after stroke onset is an  independent risk factor for long-term stroke recurrence. Methods: We examined 242 
patients (age = 72.0 js 8.7 years) hospitalized with acute ischemic stroke who had survived the first three months without 
recurrence and followed them to identify predictors of long-term stroke recurrence. We diagnosed dementia three months 
after stroke using modified DSM-111-R criteria based on neuropsychological and functional assessments. The effects of 
conventional stroke risk factors and dementia status on survival free of recurrence were estimated using Kaplan-Meier 
analyses, and the relative risks (RR) of recurrence were calculated using Cox proportional hazards models. Results: 
Dementia (RR = 2.71, 95% CI = 1.36 to 5.42); cardiac disease (RR = 2.18, CI = 1.15 to 4.12); and sex, with women at 
higher risk (RR = 2.03, CI = 1.01 to 4.10), were significant independent predictors of recurrence, while education (RR = 
1.90, CI = 0.77 to 4.68), admission systolic blood pressure >160 mm Hg (RR = 1.80, CI = 0.94 to 3.44) and alcohol intake 
exceeding 160 grams per week (RR = 1.86, CI = 0.79 to 4.38) were weakly related. Conclusions: Our results suggest that  
dementia significantly increases the risk of long-term stroke recurrence, with additional independent contributions by 
cardiac disease and sex. Cognitive impairment may be a surrogate marker for multiple vascular risk factors and larger 
infarct volume that may serve to increase the risk of recurrence. Alternatively, less aggressive medical management of 
stroke patients with cognitive impairment or noncompliance of such patients with medical therapy may be bases for an 
increased rate of stroke recurrence. 
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A number of studies have reported an elevated risk 
of long-term stroke recurrence following cerebral in- 
farction. The Framingham Study1 reported a five- 
year stroke recurrence rate of 42 percent while the 
Stroke Data Bank2 reported a two-year rate of 14 
percent. Recent community-based studies have re- 
ported five-year recurrence rates ranging from 25 to 
30 p e r ~ e n t . ~ , ~  In contrast to  stroke incidence rates,5 
stroke recurrence rates have not declined,6 and with 
increasing numbers of stroke survivors, there is a 
significant need to identify the predictors of recur- 
rence. While few risk factors for stroke recurrence 
have been consistently identified, it is likely some of 
them will differ from the recognized risk factors for 
first stroke. Identification of patient groups at in- 
creased risk of stroke recurrence may permit tar- 
geted application of secondary prevention measures 
to reduce recurrence rates. 
While the prevalence7 and incidences,9 of dementia 
following stroke are high and survival is signifi- 
cantly reduced among stroke patients with demen- 
tia,lo the prognostic implications of cognitive impair- 
ment after stroke with regard to the risk of stroke 
recurrence have not been investigated. Thus, we per- 
formed the present study to determine whether de- 
mentia diagnosed three months after ischemic stroke 
onset would be an independent risk factor for long- 
term stroke recurrence. 
Methods. Subjects. Subjects for this study were re- 
cruited among patients consecutively admitted within 30 
days of onset of ischemic stroke to Columbia-Presbyterian 
Medical Center. Eligible patients were 60 years of age or 
older, spoke English or Spanish as a primary language, 
and had a diagnosis of acute ischemic stroke of any type. 
Index ischemic stroke was defined as the acute onset of a 
focal neurologic deficit attributable to vascular disease of 
the brain and supported by CT scan (normal or relevant 
infarct) performed within one week of symptom onset. Pa- 
tients with mild to moderate degrees of aphasia were in- 
cluded, but those with severe aphasia were excluded if 
they scored <2 on the severity rating scale of the Boston 
Diagnostic Aphasia Examination (BDAE)." Additional ex- 
clusions were the presence of a concomitant primary neu- 
rologic disorder potentially affecting cerebral function (e.g., 
Parkinson's disease), primary language other than English 
or Spanish, or severe medical comorbidity (e.g., terminal 
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cancer) limiting survival over the planned follow-up period 
of five years. Informed consent was obtained from subjects 
or their family members using procedures approved by the 
Institutional Review Board of Columbia-Presbyterian 
Medical Center. 
During hospitalization, medical and neurologic histories 
were collected and each patient underwent structured neu- 
rologic examinations, cognitive assessment using the Mini- 
Mental State Examination (MMSE),IZ and functional as- 
sessments using the Barthel Index13 and the Blessed 
Functional Activity Scale (BFAS).I4 A more extensive de- 
scription of our recruitment procedures is available in an 
earlier publication on methods and baseline  finding^.^ 
Among the 297 patients who were initially enrolled, 251 
received assessments that  were adequate for the determi- 
nation of dementia status three months after stroke, while 
9 of those 251 patients were excluded due to early recur- 
rence (i.e., less than 90 days from the index stroke), leav- 
ing 242 patients eligible for this study. The mean age of 
these subjects was 72.0 2 8.7 years and their mean educa- 
tion was 10.1 ? 4.6 years. Males comprised 47.1% of the 
sample and the cohort was of mixed race-ethnicity with 
38.8% black, 34.7% white, and 26.5% Hispanic patients. 
Three months after the onset of 
stroke, subjects were administered a battery of neuropsy- 
chological tests developed for the purpose of diagnosing 
dementia in a bilingual (English and Spanish), multieth- 
nic, elderly population,15J6 and the neurologic and func- 
tional examinations were repeated. We chose an interval of 
three months following stroke onset for neuropsychological 
testing to allow sufficient time for patients to exhibit an  
essentially stable c o ~ r s e . ~ ~ J ~  Based on all available infor- 
mation gathered from the neurologic, neuropsychological, 
and functional assessments administered at the three 
month visit, dementia was diagnosed using modified DSM- 
111-R criteria.lg We required the presence of memory im- 
pairment as well as deficits in at least two other cognitive 
domains (i.e., orientation, abstract reasoning, language, 
and visuospatial function), combined with functional im- 
pairment unrelated to physical deficits, as documented 
with the BFAS. The requirement that  patients exhibit def- 
icits in memory and at least two other cognitive domains 
was intended to ensure that patients were not misclassi- 
fied on the basis of poor performance on any single mea- 
sure. To diagnose dementia in aphasic patients who were 
testable, impairment in nonverbal memory was required. 
Impairment within each cognitive domain was defined by 
performance on neuropsychological tests falling below pre- 
determined cutoff scores for each of the subtests developed 
from pilot data.15 The use of cutoff scores was intended to 
ensure that study criteria for the diagnosis of dementia 
would be objective and replicable. We have reported norms 
for this battery in our stroke and control subjects and 
consider the cutoffs to be conservative.16 Agreement on the 
diagnosis of dementia was excellent, with a Kappa of 0.96 
based on independent judgments by two raters in a sample 
of 63 patients. Based on these operationalized criteria, 62 
of the 242 patients (25.6%) were found to be demented a t  
the three month examination. The Clinical Dementia Rat- 
ingZo was determined for each patient as a measure of 
dementia severity. 
We used historical information obtained from the 
BFAS, administered a t  7 to 10 days after the index stroke, 
Dementia diagnosis. 
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to reflect the functional status of our patients in the twelve 
months preceding the stroke and to determine the major 
clinical subtypes of dementia. When there was evidence of 
functional deficits predating the index stroke, we diag- 
nosed “mixed” dementia (Alzheimer’s disease [AD] and 
stroke). In the absence of pre-existing functional problems, 
cerebrovascular disease was inferred to be the central 
mechanism for the dementia syndrome and a diagnosis of 
vascular dementia (VaD) was made. 
The definition of stroke recurrence 
was similar to that of the index stroke, but we additionally 
required that the neurologic deficit be clearly different 
from that of the index stroke, involve a different anatomic 
site or vascular territory from that of the index stroke, or 
be of a stroke subtype different from that of the index 
stroke.2 Based on combined clinical, laboratory, and neuro- 
imaging information, the stroke mechanism for each recur- 
rent event was determined using methods modified from 
the Stroke Data Bank.21 Both ischemic and hemorrhagic 
strokes were included as recurrent cerebrovascular events. 
Exact dates for all stroke recurrences were recorded and 
for those patients who had more than one stroke recur- 
rence we used the date of the first recurrence. 
Patients were re-examined annually 
with the clinical assessments described above. Scheduling 
of annual examinations was based on the date of index 
stroke onset. We performed continuous surveillance using 
the methods described above to identify cases of stroke 
recurrence. To maximize follow-up rates, we made visits to 
the subject’s homes or health care facilities if they were 
unable or unwilling to visit the medical center, and we did 
not consider them as having refused any interval examina- 
tion until a t  least four attempts had been made to contact 
and examine them. We also relied upon a daily survey of 
admissions to the medical center, information from six 
month interval telephone follow-up calls, and, in cases of 
death, review of medical records and death certificates to 
screen for stroke recurrence. Whenever possible, patients 
were examined and brain imaging was obtained at the 
time of the recurrence to support the diagnosis of recurrent 
stroke. Each patient was followed up until death or June 
30, 1993, the end of the prospective study period. 
We used survival curves obtained 
by the Kaplan-Meier product-limit methodz2 to estimate 
the proportion of patients free of recurrence in the overall 
sample and then in groups stratified by dementia status 
and other potential predictors. These included demo- 
graphic variables (i.e., age, education, sex, and race); con- 
ventional vascular risk factors (i.e., hypertension; diabetes; 
cardiac disease, with myocardial infarction, angina, con- 
gestive heart failure, valvular heart disease, and atrial 
fibrillation combined into one variable; hypercholesterol- 
emia; and cigarette smoking, defined as history of smoking 
at least one cigarette per day for at least one year); clinical 
features of the index stroke (stroke syndrome classified as 
major hemispheral versus other, reflecting the range and 
severity of neurologic deficits; vascular territory classified 
as internal carotid versus vertebrobasilar; stroke subtype 
classified as large artery atherosclerosis, lacunar, cardio- 
genic embolism, or cryptogenic, based on all available diag- 
nostic information from the index stroke evaluation;21 and 
the Barthel Index score received 7 to 10 days after the 




pressure readings on admission; and selected laboratory 
data (i.e., blood glucose on admission and cholesterol level 
determined 7 to  10 days after stroke). 
We chose to include patients with a history of prior 
stroke or TIA in our analyses because previous studies 
have identified both prior stroke and TIA as predictors of 
recur ren~e~.~~ and we wished to examine their role in our 
sample. In addition, a history of prior stroke is frequently 
present in hospitalized stroke patients2z3 and we sought a 
sample that would be representative of elderly stroke pa- 
tients to increase the generalization of our findings. Fi- 
nally, silent or asymptomatic cerebral infarction is fre- 
quently found on brain imaging even when patients have 
no history of clinically evident ~ t r o k e , ~ ~ . ~ ~  and exclusion of 
such patients from studies of stroke recurrence would se- 
verely reduce the pool of eligible subjects. 
To investigate the putative J- or U-shaped association 
between alcohol use and stroke risk,26,27 alcohol consump- 
tion was assessed as part of a structured questionnaire 
focusing on general medical risk factors, diet, and lifestyle. 
The amount and category (beer, spirits, wine) of alcohol 
typically consumed during one week was converted into 
grams of alcohol, with one standard drink (a can of beer, a 
glass of wine, or a single measure of spirits) representing 
the equivalent of 10 grams of Consumption was 
classified as >160 grams and 60 to 160 grams versus <60 
grams per week. 
The cumulative proportions of patients experiencing a 
stroke recurrence over the follow-up period were deter- 
mined in groups stratified by the above variables. Survival 
time was calculated from the date of the three-month ex- 
amination and statistical significance was determined by 
the log-rank test. Reasons for censoring included death 
unrelated to  stroke recurrence, subject drop-out, and 
reaching the end of the study period. The crude incidence 
rate (IR) of stroke recurrence, stratified by the presence of 
dementia, was calculated using life-table methods. To esti- 
mate the relative risk of stroke recurrence associated with 
the presence of dementia while adjusting for demographic 
variables and other potentially relevant factors, we fitted 
Cox proportional hazards models.28 Variables were selected 
for entry into the model based on univariate results ( p  5 
0.1) or a priori hypotheses based on previously published 
studies. 
Results. Uniuariate analyses. Among the 242 patients, 
208 (86%) completed at  least one visit after the baseline 
examination, 176 (72.7%) completed at  least two visits, 111 
(45.9%) completed at  least three visits, and 31 (12.8%) 
completed at  least four visits. Deaths unrelated to stroke 
recurrence occurred in 67 patients (27.7%) and only 5 pa- 
tients (2.1%) were lost to any follow-up. Thus, we were 
able to obtain information on stroke recurrence in the vast 
majority of patients with our surveillance methods. Me- 
dian follow-up for the cohort was 34.5 months, with a 
maximum follow-up of 59 months. Excluding deaths occur- 
ring before each planned follow-up interval, the proportion 
of patients examined among those at  risk of stroke recur- 
rence was 93.8% at  year 1, 91.3% at  year 2, 96.6% at  year 
3, and 94.6% at  year 4. During 647 person-years of follow- 
up, 45 patients had a recurrent stroke, resulting in a cu- 
mulative stroke recurrence rate of 24.0% and an unad- 
justed IR of 7.0 per 100 person-years. Cumulative stroke 
recurrence rates stratified by demographic variables, de- 
mentia status, vascular risk factors, laboratory data, and 
clinical features of the index stroke are presented in table 
1. 
Among the demographic variables, we found no effect 
for age and race but sex did exert a significant influence on 
the rate of recurrence, with women at  elevated risk. Edu- 
cation was of borderline significance, with less educated 
patients a t  elevated risk. Dementia was a significant pre- 
dictor of stroke recurrence, with almost 50% of demented 
patients having a recurrent stroke during the follow-up 
period of 59 months compared to 20% of the nondemented 
group. The unadjusted IR of stroke recurrence in the de- 
mented group was 12 per 100 person-years, compared to 
an IR of 6.0 per 100 person-years in the nondemented 
group. The cumulative proportion of patients surviving 
free of recurrence stratified by dementia status is pre- 
sented graphically in the figure. By the log rank test, sur- 
vival curves for the two groups were significantly different 
(x2 = 6 . 7 6 , ~  = 0.009). 
Among vascular risk factors, there was a trend towards 
a higher rate of recurrence in patients with cardiac dis- 
ease. Although a history of smoking was associated with a 
lower rate of recurrence, further analysis revealed a con- 
founding association between smoking and age, with smok- 
ers tending to  die at a younger age and thus not a t  risk of 
stroke recurrence. There was a trend towards a higher rate 
of stroke recurrence in patients with an admission systolic 
blood pressure (SBP) > 160 mm Hg, but a significant effect 
was not found for an elevated diastolic blood pressure 
(DBP). Laboratory data and clinical features of the index 
stroke, including stroke severity, stroke syndrome, vascu- 
lar territory, and stroke subtype, did not have a significant 
effect on the stroke recurrence rate. A history of clinically 
evident prior stroke or TIA failed to significantly affect the 
stroke recurrence rate. 
The initial Cox model included 
demographic variables alone, with sex and education 
showing trends towards significance. Women and patients 
with less than 12 years of education were at  higher risk of 
stroke recurrence in this model. When baseline dementia 
status was added to this basic demographic model, we 
identified a significant independent effect of dementia on 
the risk of recurrence, with an RR of 2.08 (95% CI = 1.09 
to 3.99). Age and race were not significant factors in this 
model. Sex and education retained their borderline effects, 
with women and patients with less than 12 years of educa- 
tion having elevated risks of recurrence (RR = 1.75, 95% 
CI = 0.91 to  3.40, and RR = 1.92, CI = 0.78 to 4.70 
respectively). 
The final model was developed by adding other vari- 
ables based on improvement in the log-likelihood ratio, as 
shown in table 2. The Cox analysis including these vari- 
ables resulted in an RR of 2.71 (95% CI = 1.36 to 5.42) for 
dementia as an independent predictor of stroke recurrence. 
Cardiac disease (RR = 2.18, 95% CI = 1.15 to 4.12) was 
also a significant predictor of stroke recurrence, as was 
sex, with women at  higher risk (RR = 2.03, 95% CI = 1.01 
to 4.10). In an effort to  determine the specific cardiac diag- 
noses associated with an increased risk of stroke recur- 
rence, we examined individual cardiac conditions in the 
Cox proportional hazards analysis, but we found no single 
cardiac condition was an independent predictor of stroke 
recurrence, probably due to small sample sizes in those 
Multivariate analyses. 
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Table 1 Cumulative stroke recurrence rates (t standard error) by demographic features, dementia status, vascular risk factors, 
laboratory data, and clinical features of the index stroke 
Subject 
characteristics 
Demographics Age (years) 
Dementia status 
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21.62 t 5.32 
20.79 t 4.98 
45.01 i- 13.55 
17.01 t 4.42 
29.64 5 5.33 
26.65 t 4.30 
15.26 t 6.30 
28.66 t 5.15 
21.25 2 6.36 
19.64 2 3.87 
45.82 i- 9.96 
21.47 t 5.06 
32.54 5 6.70 
27.54 2 7.47 
25.03 i- 4.78 
22.96 i- 4.42 
32.63 t 8.85 
25.35 t 4.17 
18.43 2 6.31 
22.88 i- 4.34 
26.37 t 6.04 
30.30 2 5.88 
17.59 -C_ 4.05 
24.77 i- 4.90 
20.58 i- 9.30 
23.38 i- 6.71 
19.30 i- 4.34 
29.16 t 5.71 
26.34 2 4.76 
20.51 t 4.90 
24.18 i- 4.99 
29.79 2 7.14 
27.13 2 5.51 
26.36 i- 6.52 
25.56 ? 8.75 
30.80 2 7.92 
23.86 5 6.16 
24.10 t 11.14 
38.18 t 11.57 
11.12 i- 4.69 
21.79 t 5.78 
29.31 t 8.09 
23.03 t 4.77 
30.76 i- 7.14 
22.88 i- 5.28 
28.72 t 5.86 
Blood glucose level was measured on admission while cholesterol level was measured 7 to  10 days after index stroke. Some recurrence 
rates are based on an incomplete sample due to missing data. 
TIA = transient ischemic attack SBP = systolic blood pressure; DBP = diastolic blood pressure. 







demented Figure. Kaplan-Meier curves repre- 
senting the cumulative proportion of 
patients surviving free of recurrence 
stratified by dementia status during 
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cardiac subgroups. Admission SBP was of borderline sig- 
nificance (RR = 1.80, 95% CI = 0.94 to 3.44) in the final 
model, as was education, with a higher risk of recurrence 
in patients with less than 12 years of education (RR = 
1.90, CI = 0.77 to 4.68). We included alcohol consumption 
in the multivariate analysis after univariate testing re- 
vealed an association between gender and alcohol use and 
its inclusion improved the log-likelihood ratio of the model. 
Table 2 Final Cox proportional hazard model of the relative risk 
of stroke recurrence for demented stroke patients compared to 
nondemented stroke patients adjusting for demographic factors 
and other relevant variables 
Relative risk (95% CI) 
Independent variables 
Dementia status (yes vs no) 
Cardiac disease (yes vs no) 




Alcohol consumption (560 g/wk) 
61-160 g/wk 0.90 (0.32-2.49) 
>160 glwk 1.86 (0.79-4.38) 
Covariates 
Age (vs 60-69 years) 
70-79 years 1.03 (0.49-2.13) 
80+ years 1.06 (0.42-2.66) 
Education (5  12 years vs >12 years) 1.90 (0.77-4.68) 
Sex (female vs male) 2.03 (1.01-4.10) 
Race (white vs nonwhite) 0.89 (0.43-1.85) 
SBP = systolic blood pressure measured in millimeters of mer- 
cury.  
5 0  6 0 months. Survival curves are sign$- 
cantly different by the log rank test 
(p = 0.009). 
Light to moderate drinking (60 to 160 grams per week) 
was not inversely associated with stroke recurrence (RR = 
0.90, 95% CI = 0.32 to 2.49), while heavy drinking (>160 
grams per week) showed a trend towards significance for 
an  elevated risk (RR = 1.86, 95% CI = 0.79 to 4.38). 
Given that we found dementia to be a significant inde- 
pendent predictor of stroke recurrence, we also examined 
the relationship between the severity of dementia and the 
magnitude of risk of stroke recurrence. In a Cox analysis, 
we found that moderate to severe dementia (corresponding 
to CDR scores of 2 2 )  was a significant independent predic- 
tor of stroke recurrence (RR = 3.03, 95% CI = 1.33 to 
6.91), while mild dementia (corresponding to a CDR score 
of 1) was weakly related (RR = 1.58, 95% CI = 0.70 to 
3.57) after adjusting for demographic variables. Addition- 
ally, prior stroke, when considered separately from TIA, 
was not a significant variable either in our univariate or 
multivariate analyses and did not significantly alter the 
calculated relative risks of the predictors when forced into 
our final multivariate model. 
Discussion. Previous studies of outcome after ce- 
rebral infarction have tended to focus on survival 
after stroke, rather than stroke r e c ~ r r e n c e , ~ ~ - ~ ~  while 
those which have investigated predictors of recur- 
rence have tended to limit their analysis to  conven- 
tional vascular risk fa~tors.'-~Jj Although previous 
studies have examined the effects of stroke-related 
cognitive impairment on functional recovery and sur- 
vival and suggested that stroke survivors with cogni- 
tive deficits have a poorer prognosis with regard to 
those our study is the first, to  our 
knowledge, to examine the role of cognitive impair- 
ment after stroke as a predictor of long-term recur- 
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rence. Recurrent stroke was frequent in our sample, 
with an overall five-year cumulative stroke recur- 
rence rate of 24.0%, which is comparable to  that of 
other s t ~ d i e s . ~ , ~  We found in our prospective investi- 
gation that the incidence of stroke recurrence was 
approximately doubled among patients with demen- 
tia following stroke relative to  nondemented pa- 
tients. Dementia after stroke remained a significant 
independent risk factor for long-term stroke recur- 
rence after adjusting for demographic variables and 
other vascular risk factors. We found no effect for 
race or age on the risk of stroke recurrence, but 
women and patients with fewer years of education 
were at higher risk of recurrent stroke in our sam- 
ple. With regard to vascular risk factors, only cardiac 
disease was an independent predictor of long-term 
stroke recurrence, although a trend towards increas- 
ing risk was noted for a systolic blood pressure (SBP) 
>160 mm Hg. In addition, we noted a weak trend 
towards an elevated risk of stroke recurrence for 
heavy alcohol consumption but no significant protec- 
tive effect for light to  moderate alcohol consumption. 
Our finding that dementia is an independent pre- 
dictor of long-term stroke recurrence is intriguing 
and could be related to  a number of pathogenic 
mechanisms. First, since stroke itself increases the 
risk of dementia,7-9 and our findings suggest that 
dementia may also cause stroke, a bidirectional 
causal link between dementia and stroke may exist, 
with dementia serving as a surrogate marker for 
larger infarct volume or multiple vascular risk fac- 
tors, and, thus, an increased stroke risk. Indirect 
support for this hypothesis is derived from several 
sources, including the observations that larger in- 
farct volumes may be associated with dementia after 
ischemic s t r ~ k e ~ ~ , ~ ~  and that the risk of dementia in 
stroke populations may be increased by exposure to  
vascular risk factors such as prior symptomatic 
stroke, myocardial infarction, and diabetes melli- 
 US.^^,^^ Data from a recently conducted, population- 
based, prospective cohort study provides further evi- 
dence in support of a bidirectional causal link 
between cognitive impairment and cerebrovascular 
disease in the elderly, having found that a low score 
on a mental status questionnaire was an indepen- 
dent risk factor for stroke incidence in initially 
stroke-free subjects aged 71 years and older.40 Inter- 
estingly, the association between cognitive impair- 
ment and the risk of a future stroke was indepen- 
dent of the significant effects of hypertension and 
diabetes. The authors proposed that silent or sub- 
clinical cerebrovascular disease may be an under- 
recognized but important risk factor for cognitive im- 
pairment in the elderly and may serve to increase 
the risk of clinically evident stroke. 
Second, the reported association between stroke- 
related dementia and the presence on CT of prior 
asymptomatic or silent brain infarcts offers a poten- 
tial mechanism underlying higher rates of recur- 
rence in demented stroke patients. Among 163 pa- 
tients with silent brain infarction in the Stroke Data 
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Bank, dementia was more frequent with increasing 
number and size of silent lesions,41 while in the 
Stroke and Aging Research Project, we have found 
multiple lacunar infarcts, both symptomatic and 
asymptomatic, to  be a significant correlate of demen- 
tia following ischemic The European Atrial 
Fibrillation Trial (EAFT) reported that patients with 
silent infarcts on brain CT had a higher risk for both 
recurrent vascular events in general (vascular death, 
myocardial infarction, systemic embolism, and 
stroke) and for recurrent stroke in ~ a r t i c u l a r . ~ ~  
Other studies have found the extent of cerebral 
white matter disease or leukoaraiosis on CT in 
stroke patients to be an independent risk factor for 
recurrent stroke and associated with an increased 
frequency of dementia.44,45 Silent brain infarcts and 
leukoaraiosis may increase susceptibility to  stroke- 
related cognitive decline by reducing cognitive re- 
serve, may be significantly more prevalent in pa- 
tients with dementia following stroke, and may serve 
as a marker for a greater burden of cerebral arterio- 
sclerosis, thereby placing these patients at higher 
risk of recurrent stroke. 
Third, dementia may be a predictor of long-term 
stroke recurrence due to  less aggressive medical 
management of patients with stroke-related cogni- 
tive deficits. Diminished intellectual competence fol- 
lowing stroke may result in patients being consid- 
ered poor candidates for secondary prevention 
programs. Physicians may be reluctant to  initiate 
oral anticoagulation with warfarin, for example, due 
to the elevated risk of hemorrhage that may result 
from inadequate monitoring and inconsistent admin- 
istration in stroke patients with significant cognitive 
deficits. Alternatively, noncompliance of demented 
stroke patients with prescribed secondary preventive 
measures due to cognitive impairment may be a ba- 
sis for an increased rate of stroke recurrence. In ad- 
dition, patients with cognitive impairment following 
stroke are significantly more likely to have func- 
tional deficits resulting in nursing home placement 
or dependent living at home,16 potentially compro- 
mising medical follow-up and management of hyper- 
tension, diabetes, and other chronic vascular risk 
factors. 
We also found cardiac disease to be a significant 
independent risk factor for long-term stroke recur- 
rence. To represent cardiac disease, we used a vari- 
able combining a broad range of cardiac conditions 
that could cause cardiogenic embolic cerebral infarc- 
tion.46,47 Small sample sizes in our subgroup analyses 
probably hindered our ability to detect effects for 
individual cardiac diseases. M a r q u a r d ~ e n ~ ~  found in 
a retrospective study that congestive heart failure, 
atrial fibrillation, and electrocardiographic abnor- 
malities were associated with higher rates of recur- 
rence, while in the Stroke Data Bank an abnormal 
first electrocardiogram was a significant risk factor 
for stroke recurrence at one year.48 The Framingham 
Study1 reported that cardiac conditions such as coro- 
nary heart disease and congestive heart failure con- 
tributed significantly to  higher five-year cumulative 
recurrence rates, while investigators in the Lehigh 
Valley Stroke Studyz3 found an approximately eight- 
fold increased risk of recurrent stroke among pa- 
tients with myocardial infarction and a pooled group- 
ing of other cardiac diseases. The recent availability 
of transesophageal echocardiography has added new 
data in support of an increased risk of recurrent 
stroke with potential cardiac sources of embolism, 
such as patent foramen ovale with inter-atrial shunt, 
left atrial thrombus, and atrial septa1 aneurysm, and 
suggests that further studies are needed to deter- 
mine the optimal management of stroke patients 
with potential cardiac sources of e m b o l i ~ m . ~ ~ ~ ~ *  
The role of hypertension in relation to stroke re- 
currence is unclear with previous studies reporting 
conflicting r e s u l t ~ . ~ - ~ , ~  We found no effect for hyper- 
tension diagnosed prior to the index stroke nor for an 
elevated DBP on admission, but we noted that an 
admission SBP >160 mm Hg increased the risk of 
long-term stroke recurrence. Irie et al.51 reported 
that patients with a poststroke SBP of 150 mm Hg or 
greater had a significantly higher stroke recurrence 
rate than those with poststroke SBP below 150 mm 
Hg. Although not specifically assessed in our pa- 
tients, isolated systolic hypertension (ISH) is com- 
mon in the elderly,52 and 36-year follow-up data from 
the Framingham Study has shown stroke incidence 
to be significantly greater in elderly patients with 
ISH.53 The Systolic Hypertension in the Elderly Pro- 
gram (SHEP) has provided further support for a crit- 
ical role of ISH in stroke, with its finding that 
stepped-care antihypertensive drug treatment of ISH 
in patients >60 years of age significantly reduced 
the five-year incidence of stroke.54 The stronger ef- 
fect of SBP compared to DBP in predicting recurrent 
stroke in our sample parallels its disproportionate 
effect in the prediction of stroke ocurrence and 
stroke-related m ~ r t a l i t y . ~ ~ , ~ ~ , ~ ~  
In case-control studies, heavy alcohol intake has 
been reported to be an independent risk factor for 
both hemorrhagic and ischemic ~ t r o k e . ~ ~ , ~ ~  Heavy al-
cohol use was reported to be an independent risk 
factor for stroke recurrence within 5 years of index 
stroke in the Northern Manhattan Stroke Study.3 
Several epidemiologic studies have suggested a 
J-shaped relationship between alcohol consumption 
and initial ischemic stroke, with low to moderate 
levels of alcohol intake having a protective effect 
against the occurrence of stroke and heavy intake 
elevating the risk of a cerebrovascular event.26z27,57 
We were unable to  confirm a J-shaped association 
between alcohol consumption and the risk of recur- 
rent stroke in our sample. Alcohol intake exceeding 
160 grams per week did result in an increased risk of 
stroke recurrence but low to moderate levels of alco- 
hol consumption (60 to 160 grams per week) were 
not associated with a protective effect. While our 
data showed that 29 of 157 nondrinkers (18.5%) and 
5 of 35 light to moderate drinkers (14.3%) experi- 
enced a recurrence over the follow-up period versus 
10 of 48 heavy drinkers (20.8%), suggesting a possi- 
ble protective effect in the light to moderate drinking 
group, small sample sizes in the light to  moderate 
and heavy drinking groups may have hampered our 
ability to  recognize significant effects. Our reliance 
on self-reports of alcohol intake may also have re- 
sulted in an underestimation of the true effect of 
heavy alcohol use in relation to the risk of stroke 
recurrence. 
Although they were treated primarily as covari- 
ates in our study, the effects of sex and education on 
stroke recurrence deserve further comment. We 
found sex to be a significant independent predictor of 
stroke recurrence, with women at elevated risk. Of 
the previous studies of factors influencing the risk of 
recurrent ~ t r ~ k e , ~ - ~ , ~ , ~ ~ . ~ ~ ~ ~ ~ , ~ ~  only the Framingham 
study1 reported an effect for gender, with men hav- 
ing almost double the rate of recurrence observed in 
women. Substantial differences in study design and 
patient type in previous studies of stroke recurrence 
make meaningful comparisons between studies diff- 
cult. In our sample, further subanalyses revealed sex 
differences in the distribution of age and alcohol in- 
take, with women tending to be older and men tend- 
ing to be heavier drinkers, suggesting that an un- 
equal distribution of stroke risk factors between the 
sexes may account for the higher rate of recurrence 
that we observed in women. This interesting finding 
needs further study to determine whether identified 
vascular risk factors interzct with gender to influ- 
ence stroke recurrence. Although we did not have the 
necessary data in our sample, age at  menopause and 
estrogen status59 are additional factors that may af- 
fect stroke recurrence in women and warrant inves- 
tigation in future studies. Education was of border- 
line significance in our multivariate analyses, with 
less educated patients experiencing a higher rate of 
recurrence. The effect of education on stroke recur- 
rence has not been previously examined and our 
finding may reflect poorer control of risk factors in 
the less educated patients. After a first stroke, pa- 
tients with less education may not be aware of the 
substantial risk of recurrent stroke, with resultant 
failure to modify diet or risk behaviors such as smok- 
ing and alcohol use. Among the less educated, lower 
socioeconomic status with resultant reduced access 
to regular health care may also affect control of vas- 
cular risk factors and may be an explanation for 
their increased susceptibility to stroke recurrence. 
The limitations of our study include an inability to 
investigate infarct volume, silent brain infarction, 
and leukoaraiosis as predictors of recurrence due to 
a lack of quantitative neuroimaging, as well as a 
restricted sample size which limited our ability to  
reliably investigate the association between the clin- 
ical subtype of dementia (e.g., AD with stroke, VaD) 
and risk of stroke recurrence. Although we might 
infer that patients with VaD would be at greater risk 
of stroke recurrence than those with mixed dementia 
due to a greater burden of cerebrovascular disease, 
our results suggest that the dementia syndrome it- 
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self would be likely to  remain an important determi- 
nant of recurrent stroke, independent of presumed 
etiology, because dementia remained a significant in- 
dependent predictor of stroke recurrence when we 
explored risk factors for cerebrovascular disease and 
characteristics of the index stroke in our multivari- 
ate models. We also lacked reliable information on 
compliance with prescribed therapies and medical 
follow-up in our sample. We plan to continue to fol- 
low our original cohort, and we are recruiting a sec- 
ond cohort to expand our observations regarding de- 
mentia and recurrent stroke, including the 
relationship between apolipoprotein E genotype and 
risk of stroke recurrence. Further prospective stud- 
ies of stroke patients are warranted to investigate 
the role of silent stroke, larger infarct volumes, and 
cerebral white matter disease as predictors of stroke 
recurrence and how they contribute to the pathogen- 
esis of stroke-related cognitive decline. 
We found that dementia following stroke is a po- 
tent risk factor for recurrent stroke, suggesting that 
careful attention should be paid to  the detection of 
cognitive impairment in stroke patients. The recog- 
nition of dementia in stroke survivors may identify a 
subgroup at  higher risk for recurrence, providing an 
opportunity for targeted intervention. For example, 
the institution of supervised treatment programs for 
stroke survivors with dementia may lower rates of 
stroke recurrence in this group. Our results also sup- 
port prompt evaluation and treatment of cardiac dis- 
ease in stroke survivors to prevent recurrent stroke 
due to cardiogenic cerebral embolism. Education of 
stroke patients and their families, in particular those 
who are less educated or from lower socioeconomic 
strata, may increase their awareness of risk factors 
for stroke recurrence, encourage the modification of 
risk-prone behaviors, and improve compliance with 
medical therapies, leading to a better outcome fol- 
lowing ischemic stroke. 
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